Fertility startup Gameto has received permission from the FDA to see if its ovary-in-a-dish technology can make in vitro ...

VC, a venture capital firm that has spread its bets across multiple industries, including biotech and digital health, is ...

Teva CEO Richard Francis expects continued growth for Austedo despite future Medicare price negotiations, maintaining $2.5B ...

Zentalis Pharmaceuticals is axing about 40% of its staff and doubling down on advancing its only pipeline candidate as part ...

A Delaware judge issued a split ruling in a bizarre legal squabble over the IPO plans of Aurion Biotech, which should allow ...

The Trump ad­min­is­tra­tion said on Wednes­day it will con­sid­er “op­por­tu­ni­ties to bring greater trans­paren­cy” to the ...

Em­bat­tled ge­net­ics test­ing gi­ant 23andMe is think­ing of sell­ing it­self as it runs out of cash. The com­pa­ny needs ...

Curie.Bio reveals $340M seed fund, Cullinan's zipalertinib succeeds in lung cancer trial, Benchling cuts 10% staff, I-Mab reduces workforce, Regulus shares Phase 1b data, Imvax raises $29M ...

Lonza said Wednesday morning it is on the hunt for deals to increase its capacity and technology offerings, which comes after ...

Novo Nordisk is asking a federal appeals court to make haste on its case challenging the Inflation Reduction Act's drug ...

Affini-T Therapeutics appears to have cut staff last week, according to LinkedIn posts from people who say they are or were ...

President Donald Trump’s communications and travel freeze at HHS may be part of the reason an upcoming FDA advisory committee ...